Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-3.82	74.93	77.91
Graham Fair Price	2.79	45.87	44.63
PEG	446.21	-13.57	2.48
Price/Book	-7.26	10.00	10.78
Price/Cash Flow	126.92	261.30	115.15
Prices/Earnings	2.05	27.24	26.69
Price/Sales	-8.76	38.42	42.11
Price/FCF	126.92	261.30	115.15
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-3.93	0.68	0.71
Operating Margin	-8.41	0.44	0.48
ROA	-7.05	0.05	0.05
ROE	0.10	0.09	-9.12
ROIC	0.07	0.06	-5.29
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.05	0.69	-92.46
Dividends QOQ	< 0.005	0.10	2877.11
EBIT QOQ	0.11	< 0.005	-95.32
EPS QOQ	0.11	-0.02	-81.32
FCF QOQ	0.04	-0.56	1220.52
Revenue QOQ	< 0.005	0.10	1568.01
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	16.56	7.41	-55.28
Days Sales Outstanding (DSO)	58.85	62.15	5.62
Inventory Turnover	5.43	12.15	123.60
Debt/Capitalization	0.32	0.31	-1.74
Quick Ratio	1.45	1.02	-29.42
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	29.61	31.92	7.82
Cash	19.31	10.85	-43.81
Capex	-1.33	-1.30	1.95
Free Cash Flow	2.77	1.22	-55.93
Revenue	7.58	8.31	9.60
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.66	1.22	-26.78
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.69	2.72	296.28
Naive Interpretation	Member

06 - Financial Health · Weak

Rating